fig3
Figure 3. Mechanisms of ferroptosis inhibition in macrophages. PUFAs undergo esterification in the presence of ACSL4 and LPCAT3 to produce PL-PUFAs, which subsequently undergo peroxidation in the presence of ROS generated by the Fenton reaction or enzymatic reactions such as LOXs and POR to form PL-PUFA-OOH, which accumulates on the cell membrane and ultimately leads to ferroptosis. System xc- can exchange extracellular cystine and cellular glutamate for the synthesis of GSH, and GPX4 converts PL-PUFA-OOH to PL-PUFA-OH, while simultaneously oxidizing GSH to GSSG. Another ferroptosis mechanism is the FSP1/CoQ10/NAD(P)H axis, which reduces CoQ10 to CoQ10H2 using NADPH. Moreover, FSP1 exerts an anti-ferroptotic effect by regenerating vitamin E and promoting VKH2 production. Furthermore, GCH1 synthesizes GTP into BH4/BH2, which inhibits the oxidation of PL-PUFAs, and BH4 exerts an anti-lipid peroxidation effect by promoting the synthesis of CoQ10. In mitochondria, DHODH facilitates CoQ10H2 synthesis and inhibits ferroptosis in the inner mitochondrial membrane. MBOAT replaces PL-PUFAs with MUFAs incorporated into phospholipids to prevent PUFA oxidation. Additionally, iPLA2β inhibits ferroptosis by sheerly releasing oxidized PUFAs on phospholipids. Created in BioRender. Fan, F. (2026) https://BioRender.com/o50j697. PUFAs: Polyunsaturated fatty acids; ACSL4: acyl-CoA synthetase long-chain family member 4; LPCAT3: lysophosphatidylcholine acyltransferase 3; PL-PUFA: phospholipid containing polyunsaturated fatty acid chain; ROS: reactive oxygen species; LOXs: lipoxygenases; POR: p450 oxidoreductase; PL-PUFA-OOH: phospholipids with peroxidized polyunsaturated fatty acyl tail; GSH: glutathione; GPX4: glutathione peroxidase 4; GSSG: glutathione disulfide; Glu: glutamate; Cys: Cysteine; FSP1: ferroptosis suppressor protein 1; VKH2: vitamin K hydroquinone; GCH1: GTP cyclohydrolase 1; GTP: guanosine triphosphate; BH4: tetrahydrobiopterin; BH2: dihydrobiopterin; DHODH: dihydroorotate dehydrogenase; MBOAT: membrane-bound O-acyltransferase; MUFA: monounsaturated fatty acids; iPLA2β: calcium-independent phospholipase A2 beta; LIP: labile iron pool; PL-MUFA: phospholipid containing monounsaturated fatty acid chain; System xc-: cystine/glutamate antiporter; CoQ10: coenzyme Q10; CoQ10H2: ubiquinol (reduced coenzyme Q10); NADPH: nicotinamide adenine dinucleotide phosphate (reduced form); NADP+: nicotinamide adenine dinucleotide phosphate (oxidized form); PL-PUFA-OH: phospholipid with hydroxylated polyunsaturated fatty acyl tail; PUFA-CoA: polyunsaturated fatty acyl-coenzyme A.






